Keywords: revlimid, found, prolong, time, progression, multiple, myeloma

Revlimid found to prolong time to progression of multiple myeloma

Article | 30 May 2005

Print This

Results from Special Protocal Assessment trials presented at the American Society of Clinical Oncology meeting in Orlando, Florida, show that ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in